Table 2.

We established a COX model of six hub genes and immune cells in patients with thymoma

	Coef	HR	P-value	95% CI
Age	0.182	1.2	0.032	1.016–1.417
Gender	−0.644	0.525	0.589	0.051–5.438
Purity	1.787	5.973	0.513	0.028–1266.668
B cell	−56.649	0	0.029	0–0.003
CD8 T cell	−14.822	0	0.447	0–1.41E+10
CD4 T cell	−44.501	0	0.089	0–876.375
Macrophage	−16.213	0	0.401	0–2.53E+09
Neutrophil	−80.659	0	0.114	0–2.89E+08
Dendritic	47.627	4.83E+20	0.145	0–3.31E+48
HMGA1	−2.364	0.094	0.101	0.006–1.585
MTA1	2.38	10.803	0.214	0.254–459.641
EZH2	1.579	4.85	0.38	0.143–164.672
FOS	0.558	1.747	0.078	0.939–3.253
TFAP2A	−1.917	0.147	0.044	0.023–0.954
TP53	2.104	8.197	0.243	0.24–280.172

HR, hisk risk; CI, confidence interval; Coef, coefficient.